Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2010, Article ID 285952, 4 pages
http://dx.doi.org/10.4061/2010/285952
Case Report

When You are About to Diagnose Chronic Hemolytic Uremic Syndrome, Please Think More Deep

Pediatric Department, Zagazig University, Zagazig 44519, Egypt

Received 19 June 2010; Accepted 11 October 2010

Academic Editor: Ramesh Khanna

Copyright © 2010 Doaa Mohammed Youssef and Doaa Mostafa Tawfeek. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ravelli and A. Martini, “Antiphospholipid syndrome,” Pediatric Clinics of North America, vol. 52, no. 2, pp. 469–491, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. A. Ravelli and A. Martini, “Antiphospholipid antibody syndrome in pediatric patients,” Rheumatic Disease Clinics of North America, vol. 23, no. 3, pp. 657–676, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Olive, E. Andre, O. Brocard, P. Labrude, and P. Alexandre, “lupus erythemateux dissemine revele par des thrombophlebitres des members inferieurs,” Arch Franc de Pediatr, vol. 36, no. 9, pp. 959–960, 1979. View at Google Scholar
  4. W. A. Wilson, A. E. Gharavi, T. Koike et al., “International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an International Workshop,” Arthritis and Rheumatism, vol. 42, no. 7, pp. 1309–1311, 1999. View at Google Scholar
  5. R. A. Asherson, R. Cervera, J.-C. Piette et al., “Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients,” Medicine, vol. 77, no. 3, pp. 195–207, 1998. View at Publisher · View at Google Scholar
  6. E. von Scheven, D. V. Glidden, and M. E. Elder, “Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome,” Arthritis and Rheumatism, vol. 47, no. 4, pp. 414–420, 2002. View at Google Scholar · View at Scopus
  7. E. Daugas, D. Nochy, D. L. T. Huong et al., “Antiphospholipid syndrome nephropathy in systemic lupus erythematosus,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 42–52, 2002. View at Google Scholar · View at Scopus
  8. G. Finnazzi, R. Marchioli, and T. Barbui, “A randomized clinical trial of oral anticoagulant therapy in patients with antiphosphlipd syndrome,” Thromb Haemost, vol. 1, p. 365, 2003. View at Google Scholar
  9. R. A. Asherson, R. Cervera, P. G. De Groot et al., “Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines,” Lupus, vol. 12, no. 7, pp. 530–534, 2003. View at Publisher · View at Google Scholar · View at Scopus